Eureka Therapeutics

Eureka Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel T-cell therapies to improve the lives of patients with cancers. The company is developing safer and more effective T-cell therapies for the treatment of solid tumors and hematologic malignancies. Its lead programs are focusing on liver cancer indications. The company is headquartered in the San Francisco Bay Area.